Back To Schedule
Tuesday, October 19 • 11:15am - 11:35am
Executive Interview: Thomas VanCott, Global Head of Product Development, Cell & Gene Therapy

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

avatar for Rebecca Willumson

Rebecca Willumson

Publisher, Fierce Biotech, Fierce Pharma and Fierce Healthcare, Questex

avatar for Thomas VanCott, Ph.D.

Thomas VanCott, Ph.D.

VP and Global Head of Product Development, Catalent Cell and Gene Therapy
Dr. VanCott joined Catalent through its acquisition of Paragon Gene Therapy in 2019. Prior to Paragon he spent 14 years as the President and CEO of Advanced Bioscience Laboratories Inc. (ABL), and previously held several positions at the Henry M. Jackson Foundation for the Advancement... Read More →

Tuesday October 19, 2021 11:15am - 11:35am EDT